Polycystic ovary syndrome and abnormal glucose tolerance

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · see citing works

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

Clark, A. M., Thornley, B., Tomlinson, L., Galletley, C., & Norman, R. J. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1502 · Cited by 789 · see citing works

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786 · see citing works

Health care-related economic burden of the polycystic ovary syndrome during the reproductive life Span

Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0628 · Cited by 537 · see citing works

The role of lifestyle modification in polycystic ovary syndrome

Norman, R. J., Davies, M. J., Lord, J., & Moran, L. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00612-4 · Cited by 326 · see citing works

Molecular mechanisms of insulin resistance in polycystic ovary syndrome

Diamanti-Kandarakis, E., & Papavassiliou, A. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.006 · Cited by 301 · see citing works

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0110 · Cited by 279 · see citing works

Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome

Meyer, C., McGrath, B. P., & Teede, H. J. (2007) · Diabetes Care · doi:10.2337/dc06-0618 · Cited by 148 · see citing works

Insulin Resistance, the Metabolic Syndrome, Diabetes, and Cardiovascular Disease Risk in Women with PCOS

Teede, H. J., Hutchison, S. K., Zoungas, S., & Meyer, C. (2006) · Endocrine · doi:10.1385/endo:30:1:45 · Cited by 147 · see citing works

Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association

Twigg, S. M., Kamp, M. C., Davis, T. M. E., Neylon, E. K., & Flack, J. R. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00998.x · Cited by 133 · see citing works

Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management

Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02208.x · Cited by 119 · see citing works

Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome

Dabadghao, P., Roberts, B. J., Wang, J. J., Davies, M. J., & Norman, R. J. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01273.x · Cited by 39 · see citing works

Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline

Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379 · see citing works

Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins

Cassar, S., Teede, H. J., Moran, L., Joham, A. E., Harrison, C. L., Strauss, B. J., & Stepto, N. K. (2014) · Clinical Endocrinology · doi:10.1111/cen.12557 · Cited by 73 · see citing works

The Childbearing Concerns and Related Information Needs and Preferences of Women of Reproductive Age with a Chronic, Noncommunicable Health Condition: A Systematic Review

Holton, S., Kirkman, M., Rowe, H. J., & Fisher, J. (2012) · Women s Health Issues · doi:10.1016/j.whi.2012.08.001 · Cited by 26 · see citing works

Resistência à insulina em mulheres com síndrome dos ovários policísticos: relação com as variáveis antropométricas e bioquímicas

Pontes, A. G., Rehme, M. F. B., Martins, A. M. V. D. C., Micussi, M. T. A. B. C., Maranhão, T. M. D. O., Pimenta, W. P., & Pontes, A. (2012) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032012000200006 · Cited by 23 · see citing works

Polycystic ovary syndrome and abnormalities in glucose tolerance

Bhattacharya, S. M. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.11.031 · Cited by 15 · see citing works

Serum metabolomics probes the molecular mechanism of action of acupuncture on metabolic pathways related to glucose metabolism in patients with polycystic ovary syndrome–related obesity

Yang, N., Ma, K., Liu, W., Zhang, N., Shi, Z., Ren, J. M., Xu, W., Li, Y., Su, R., Liang, Y., et al. (2023) · Biomedical Chromatography · doi:10.1002/bmc.5710 · Cited by 5 · see citing works

Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome

Cheung, N. W., & Oats, J. J. N. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01547.x · Cited by 4 · see citing works

Polycystic ovary syndrome

Mazza, D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3871-8.10006-2 · Cited by 1 · see citing works

Infertility and Subfertility Cofactors in Women with PCOS

Shavit, T., & Tulandi, T. (2017) · Springer eBooks · doi:10.1007/978-3-319-45534-1_6

WITHDRAWN: Serum metabolomics probes the molecular mechanism of action of acupuncture on metabolic pathways related to glucose metabolism in obese PCOS: a randomized controlled trialPreprint

Yang, N., Ma, K., Liu, W., Shi, Z., Wang, S., Zhang, N., Ren, J. M., Xu, W., Li, Y., Su, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2136865/v1

WITHDRAWN: Serum metabolomics probes the molecular mechanism of action of acupuncture on metabolic pathways related to glucose metabolism in obese PCOS: a randomized controlled trialPreprint

(2022) · Research Square · doi:10.21203/rs.3.rs-2136865/v2

Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome

Cheung, N. W., & Oats, J. J. N. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01547.x · Cited by 4 · see citing works

RESEARCH Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome

Dabadghao, P., Roberts, B. J., Wang, J., Davies, M. J., & Norman, R. J. (2010)

Abnormality in glucose metabolism in polycystic ovary syndrome (PCOS)

Pathan, F., Zaman, A. A., Faruque, O. M., Hassan, Z., Fuerdous, H. S., & Latif, Z. A. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)81808-2

Survey of physicians practice on diagnosis and treatment of abnormal glucose metabolism in women with polycystic ovary syndrome

Abdel-Rahman, M., Abdellah, A. H., Ismail, S., & Hurd, W. W. (2010) · F1000Research · doi:10.7490/f1000research.417.1

[The polycystic ovary syndrome].

Alieva, E. A. (1990) · PubMed